Operations Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


OPERATIONS RESEARCH
Vol. 56, No. 6, November-December 2008, pp. 1366-1381
DOI: 10.1287/opre.1080.0571
This Article
Right arrow Full Text (PDF)
Right arrow e-companion
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Long, E. F.
Right arrow Articles by Brandeau, M. L.
Right arrow Search for Related Content

Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics

Elisa F. Long, Naveen K. Vaidya, Margaret L. Brandeau

School of Management, Yale University, New Haven, Connecticut 06520
Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico 87545
Department of Management Science and Engineering, Stanford University, Stanford, California 94305

elisa.long{at}yale.edu
nvaidya{at}nanl.gov
brandeau{at}stanford.edu

A co-epidemic arises when the spread of one infectious disease stimulates the spread of another infectious disease. Recently, this has happened with human immunodeficiency virus (HIV) and tuberculosis (TB). We develop two variants of a co-epidemic model of two diseases. We calculate the basic reproduction number (R0), the disease-free equilibrium, and the quasi-disease-free equilibria, which we define as the existence of one disease along with the complete eradication of the other disease, and the co-infection equilibria for specific conditions. We determine stability criteria for the disease-free and quasi-disease-free equilibria. We present an illustrative numerical analysis of the HIV-TB co-epidemics in India that we use to explore the effects of hypothetical prevention and treatment scenarios. Our numerical analysis demonstrates that exclusively treating HIV or TB may reduce the targeted epidemic, but can subsequently exacerbate the other epidemic. Our analyses suggest that coordinated treatment efforts that include highly active antiretroviral therapy for HIV, latent TB prophylaxis, and active TB treatment may be necessary to slow the HIV-TB co-epidemic. However, treatment alone may not be sufficient to eradicate both diseases. Increased disease prevention efforts (for example, those that promote condom use) may also be needed to extinguish this co-epidemic. Our simple model of two synergistic infectious disease epidemics illustrates the importance of including the effects of each disease on the transmission and progression of the other disease.

Subject classifications: health care; epidemiology; treatment; simulation; applications; infectious disease co-epidemic; epidemic control; HIV; tuberculosis; India.
History: Received December 2006; revision received December 2007; accepted December 2007.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by INFORMS.